Cite
Immunotherapy in Stage III-IV Colon Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
MLA
Horesh, Nir, et al. “Immunotherapy in Stage III-IV Colon Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.” Journal of Immunotherapy, vol. 47, no. 8, Oct. 2024, pp. 342–50. EBSCOhost, https://doi.org/10.1097/CJI.0000000000000520.
APA
Horesh, N., Emile, S. H., Garoufalia, Z., Gefen, R., Peige Zhou, Nagarajan, A., & Wexner, S. D. (2024). Immunotherapy in Stage III-IV Colon Cancer: A Propensity Score-Matched Analysis of the National Cancer Database. Journal of Immunotherapy, 47(8), 342–350. https://doi.org/10.1097/CJI.0000000000000520
Chicago
Horesh, Nir, Sameh H. Emile, Zoe Garoufalia, Rachel Gefen, Peige Zhou, Arun Nagarajan, and Steven D. Wexner. 2024. “Immunotherapy in Stage III-IV Colon Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.” Journal of Immunotherapy 47 (8): 342–50. doi:10.1097/CJI.0000000000000520.